ID: ALA1830608

Max Phase: Preclinical

Molecular Formula: C34H26F3N5O

Molecular Weight: 577.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccncc1)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1

Standard InChI:  InChI=1S/C34H26F3N5O/c35-34(36,37)32-22-31(26-7-12-30-25(21-26)6-5-23-3-1-2-4-29(23)30)42(39-32)28-10-8-27(9-11-28)40-17-19-41(20-18-40)33(43)24-13-15-38-16-14-24/h1-16,21-22H,17-20H2

Standard InChI Key:  AZOIDPNEOWUHEN-UHFFFAOYSA-N

Associated Targets(Human)

3-phosphoinositide dependent protein kinase-2, PDK2 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 577.61Molecular Weight (Monoisotopic): 577.2089AlogP: 7.22#Rotatable Bonds: 4
Polar Surface Area: 54.26Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.18CX LogP: 6.69CX LogD: 6.69
Aromatic Rings: 6Heavy Atoms: 43QED Weighted: 0.21Np Likeness Score: -1.19

References

1. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, Kulp SK, Chen CS..  (2011)  Identification and characterization of a novel integrin-linked kinase inhibitor.,  54  (18): [PMID:21823616] [10.1021/jm2007744]

Source